Medical Oncology Practice Valuation Art and Science The Oncology Valuation Series November 27, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. “In the short [...]
Read more
EBITDA – The Oncology Valuation Series
EBITDA What is it, and why does it matter? The Oncology Valuation Series November 21, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. My [...]
Read more
MIPS for Medical Oncology Practices – Strategic Considerations
MIPS/MACRA 2018 Strategic Considerations for Medical Oncology Practices Implications of a Zero Sum Game Wes Chapman December 2017 A Doomsday Solution to a Zero Sum [...]
Read more
Financial & Operational Requirements of Oncology Super Groups
The Oncology Care Model (OCM) Financing & Operational Requirements of Super Groups Making Value Based Care Work for Community Oncology Wes Chapman April 28, [...]
Read more